GlassScriptPhysician profile
Derek Daniel Prabharasuth
NPI 1164846986
$6,543.06
in general payments reported to CMS, 2019-2025
42 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $967 · 2020: $137 · 2021: $549 · 2022: $1,745 · 2023: $926 · 2024: $674 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,077 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,077.17 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,220.29 | 2022-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $674.52 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $532.68 | 2022-2025 | Erleada, Akeega |
| Coloplast Corp | $438.16 | 2019-2025 | Titan |
| Zyla Life Sciences, INC. | $335.57 | 2019 | |
| Astellas Pharma US INC | $308.77 | 2019-2024 | Myrbetriq |
| Axonics, INC. | $306.84 | 2021-2024 | Axonics |
| Boston Scientific Corporation | $298.37 | 2019-2025 | Ams 700, General - Erectile Dysfunction |
| Pfizer INC. | $267.02 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $257.17 | 2021-2024 | Prolaris |
| Axogen | $148.51 | 2025 | |
| 180 Medical, INC. | $141.53 | 2022-2025 | Gentlecath, Gentlecath Glide |
| Urovant Sciences INC | $137.64 | 2021-2022 | |
| Medtronic USA, INC. | $128.56 | 2019-2020 | |
| Abbvie INC. | $117.42 | 2022-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Prabharasuth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.